November 2020 Update:
...
Please mark your calendars for a special event and join us on Wednesday, October 28, from 1:00pm to 3:30pm ET via Zoom Webinar to celebrate the launch of the HMS Ideation Hub (I-Hub) and HMS Translator. The symposium will feature a special discussion about emerging techniques, the future of medicine, and the direction of the industry as well as presentations by (in order of appearance):
Caroline Shields Walker Professor of Medicine, Harvard Medical School
Founder and Chairman, Access Industries
The "Frontiers in Therapeutics" panel discussion will be moderated by Mark Namchuk and feature the following panelists:
The I-Hub (Ideation Hub) at Harvard Medical School is a new initiative that aims to build community and catalyze ideation in therapeutics science, help faculty and students assemble interdisciplinary teams to prosecute translational projects, and provide early-stage support.
The Translator at Harvard Medical School is a new organization that is tasked with accelerating the movement of fundamental science at Harvard Medical School toward the medicines of tomorrow. The Translator works across a number of disease areas and therapeutic modalities via several translational research programs.
...
Agenda
1:00pm
|
Opening Remarks
|
George Q. Daley, PhD
Dean of the Faculty of Medicine, Harvard University
Caroline Shields Walker Professor of Medicine, Harvard Medical School |
|
1:10pm
|
Presentation of I-Hub
|
Tim Mitchison, PhD
Director of the I-Hub, Harvard Medical School
Hasib Sabbagh Professor of Systems Biology, Harvard Medical School
|
|
1:25pm
|
Presentation of Q-FASTR
|
Ifat Rubin-Bejerano, PhD
Director of Translational Research Programs, Harvard Medical School
|
|
1:35pm
|
Presentation of Translator
|
Mark Namchuk, PhD
Executive Director of Therapeutics Translation, Harvard Medical School
|
|
2:00pm
|
BREAK
|
2:10pm
|
Therapeutics Graduate Program Student Lightning Talks
|
2:40pm
|
Frontiers in Therapeutics Panel Discussion
|
Mark Namchuk, PhD
Executive Director of Therapeutics Translation, Harvard Medical School
Linda Avey
Co-Founder and Chief Executive Officer, Precisely, Inc.
Kevin Bitterman, PhD
Partner, Atlas Venture
Jose-Carlos Gutiérrez-Ramos, PhD
Vice President, Global Drug Discovery, AbbVie
Timothy A. Springer, PhD
Latham Family Professor of Medicine, Professor Pediatrics
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School
Program in Cellular and Molecular Medicine, Boston Children's Hospital
Co-Founder and Executive Chair, Institute for Protein Innovation
|
|
3:20pm
|
Closing Remarks
|
|
Len Blavatnik, MBA ’89
Founder and Chairman, Access Industries |